Correction

Published on 16 Jan 2023

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

in Cancer Genetics and Oncogenomics

Xinyao Hu
Hua Zhu
Shi Feng
Chaoqun Wang
Yingze Ye
Xiaoxing Xiong

Frontiers in Genetics

doi 10.3389/fgene.2022.1117731

1,071 views
1 citation

Original Research

Published on 16 Jan 2023

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma

in Cancer Genetics and Oncogenomics

Munan Zhao
Wei Li

Frontiers in Genetics

doi 10.3389/fgene.2023.955466

2,825 views
1 citation

Original Research

Published on 16 Jan 2023

Candidate targets of copy number deletion events across 17 cancer types

in Cancer Genetics and Oncogenomics

Qingyao Huang
Michael Baudis

Frontiers in Genetics

doi 10.3389/fgene.2022.1017657

1,710 views

Original Research

Published on 16 Jan 2023

Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors

in Cancer Genetics and Oncogenomics

Refaat A. Eid
Muhammad Alaa Eldeen
Mohamed A. Soltan
Mubarak Al-Shraim
Majed Aldehri
Leena S. Alqahtani
Ghadi Alsharif
Sarah Albogami
Ibrahim Jafri
Eman Fayad

Frontiers in Genetics

doi 10.3389/fgene.2022.1008502

3,087 views
6 citations

Original Research

Published on 13 Jan 2023

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis

in Cancer Genetics and Oncogenomics

Zhe Zhang
Xiaoli Shen
Zilong Tan
Yuran Mei
Tianzhu Lu
Yulong Ji
Sida Cheng
Yu Xu
Zekun Wang
Xinxian Liu

Frontiers in Genetics

doi 10.3389/fgene.2022.1053263

5,730 views
11 citations

Original Research

Published on 12 Jan 2023

Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature

in Cancer Genetics and Oncogenomics

Jinlin Zhou
Dehe Chen
Shiguo Zhang
Chunmei Wang
Li Zhang

Frontiers in Genetics

doi 10.3389/fgene.2022.1039983

4,214 views
4 citations

Original Research

Published on 12 Jan 2023

LGALS1 was related to the prognosis of clear cell renal cell carcinoma identified by weighted correlation gene network analysis combined with differential gene expression analysis

in Cancer Genetics and Oncogenomics

Jiang Fang
Xinjun Wang
Jun Xie
Xi Zhang
Yiming Xiao
JinKun Li
Guangcheng Luo

Frontiers in Genetics

doi 10.3389/fgene.2022.1046164

3,604 views
1 citation

Mini Review

Published on 12 Jan 2023

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy

in Cancer Genetics and Oncogenomics

Sotiris Loizides
Anastasia Constantinidou

Frontiers in Genetics

doi 10.3389/fgene.2022.1095839

7,312 views
40 citations

Original Research

Published on 12 Jan 2023

A cellular senescence-related genes model allows for prognosis and treatment stratification of hepatocellular carcinoma: A bioinformatics analysis and experimental verification

in Cancer Genetics and Oncogenomics

Jiaming Li
Rongzhi Tan
Jie Wu
Wenjie Guo
Yupeng Wang
Guoxing You
Yuting Zhang
Zhiyong Yu
Yan Geng
Jie Zan

Frontiers in Genetics

doi 10.3389/fgene.2022.1099148

3,571 views
2 citations

Original Research

Published on 12 Jan 2023

Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme

in Cancer Genetics and Oncogenomics

Yuling Yang
Xing Fu
Runsha Liu
Lijuan Yan
Yiping Yang

Frontiers in Genetics

doi 10.3389/fgene.2022.1033572

3,657 views
2 citations

Systematic Review

Published on 12 Jan 2023

Individual effects of GSTM1 and GSTT1 polymorphisms on cervical or ovarian cancer risk: An updated meta-analysis

in Cancer Genetics and Oncogenomics

Jing Ye
Yi-Yang Mu
Jiong Wang
Xiao-Feng He

Frontiers in Genetics

doi 10.3389/fgene.2022.1074570

2,078 views
3 citations

Original Research

Published on 12 Jan 2023

Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma

in Cancer Genetics and Oncogenomics

Ziyu Xun
Yanyu Wang
Junyu Long
Yiran Li
Xu Yang
Huishan Sun
Haitao Zhao

Frontiers in Genetics

doi 10.3389/fgene.2022.1034979

2,411 views

Original Research

Published on 11 Jan 2023

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer

in Cancer Genetics and Oncogenomics

Yuhang Wang
Kai Wang
Han Zhang
Xiaoteng Jia
Xin Li
Shuai Sun
Daqiang Sun

Frontiers in Genetics

doi 10.3389/fgene.2022.1068462

3,932 views
4 citations

Original Research

Published on 10 Jan 2023

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit

in Cancer Genetics and Oncogenomics

Yue Hou
Sijing Qiao
Miao Li
Xue Han
Xuan Wei
Yingxin Pang
Hongluan Mao

Frontiers in Genetics

doi 10.3389/fgene.2022.1090640

6,238 views
14 citations

Editorial

Published on 10 Jan 2023

Editorial: Molecular basis of epigenetic regulation in cancer therapies

in Cancer Genetics and Oncogenomics

Angeles Carlos-Reyes
Susana Romero-Garcia
César López-Camarillo
Guillermo Barreto
Heriberto Prado-Garcia

Frontiers in Genetics

doi 10.3389/fgene.2022.1115353

1,220 views

Review

Published on 10 Jan 2023

Epigenetic modifications in esophageal cancer: An evolving biomarker

in Cancer Genetics and Oncogenomics

Wen-Jian Liu
Yuan Zhao
Xu Chen
Man-Li Miao
Ren-Quan Zhang

Frontiers in Genetics

doi 10.3389/fgene.2022.1087479

4,008 views
7 citations

Navigation group

Articles

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma

Candidate targets of copy number deletion events across 17 cancer types

Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis

Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature

LGALS1 was related to the prognosis of clear cell renal cell carcinoma identified by weighted correlation gene network analysis combined with differential gene expression analysis

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy

A cellular senescence-related genes model allows for prognosis and treatment stratification of hepatocellular carcinoma: A bioinformatics analysis and experimental verification

Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme

Individual effects of GSTM1 and GSTT1 polymorphisms on cervical or ovarian cancer risk: An updated meta-analysis

Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit

Editorial: Molecular basis of epigenetic regulation in cancer therapies

Epigenetic modifications in esophageal cancer: An evolving biomarker